NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.07
-0.95 (-13.53%)
At close: May 27, 2026, 4:00 PM EDT
6.31
+0.24 (3.95%)
After-hours: May 27, 2026, 6:52 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $21.9 million as of May 27, 2026. Its market cap has increased by 75.04% in one year.
Market Cap
21.90M
Enterprise Value
-4.22M
1-Year Change
75.04%
Ranking
Category
Stock Price
$6.07
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $21.90M, a decrease of -94.98%. That is a compound annual growth rate of -34.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 25.33M | -49.09% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 26.05M |
| Celularity | 25.96M |
| Palatin Technologies | 25.70M |
| BriaCell Therapeutics | 25.58M |
| Jasper Therapeutics | 25.55M |
| Tempest Therapeutics | 25.39M |
| Vistagen Therapeutics | 25.23M |
| Pluri | 24.89M |